Research Priorities - Cardiovascular
  • Article
  • Apr 11 2022

The scholarship is the preeminent undergraduate award of its kind in the fields of natural sciences, engineering and mathematics. Chauhan is among 417 students nationwide selected to receive the honor from a pool of over 5,000 students.

  • Article
  • Mar 18 2022

Xiangan Li, Saha Cardiovascular Research Center, found that a synthetic form of high-density lipoprotein (HDL) provided protection against sepsis in mice.

  • Article
  • Jan 28 2022

The 8th annual Healthy Hearts for Women Symposium will be held virtually on February 4, 2022, highlighting new scientific advances in women's heart health.

  • Article
  • Sep 14 2021

Hosted by the University of Kentucky Saha Cardiovascular Research Center and the UK Gill Heart & Vascular Institute, the event celebrates innovative research in cardiovascular health.

  • Video
  • Nov 20 2020

Depression can be harder to address in rural parts of Kentucky where not only is there a shortage of mental health providers, there is a stigma surrounding mental health.

  • Article
  • Oct 27 2020

Dr. Emma Birks, UK HealthCare's heart failure section chief, is working on a new treatment therapy that recovers the hearts of some patients with advanced-stage chronic heart failure and ultimately cut down the number of heart transplants needed.

  • Article
  • Oct 9 2020

Mudd-Martin is testing the effectiveness of two interventions aimed at encouraging healthy behaviors such as physical activity, healthy eating and smoking cessation for the populations of rural areas of Bourbon, Rowan, Nicholas and other nearby counties.

  • Article
  • Sep 3 2020

The mission of Sarnoff Cardiovascular Research Foundation is to develop medical students throughout their careers into the next generation of leaders in cardiovascular innovation, research and medicine by providing mentored research experience and lifelong community.

  • Article
  • Sep 2 2020

A new University of Kentucky College of Medicine study provides insight into how a protein called angiotensinogen (AGT) contributes to blood pressure regulation and atherosclerosis.

  • Article
  • Apr 29 2020

“Both areas will answer important questions about how platelets work, which could directly contribute to drug development for human diseases, especially thrombotic diseases and chronic viremia,” Whiteheart said.